What is the clinical evidence from this study?

Population: Patients undergoing coronary angiography (n=34). Intervention: Nitroglycerin vs. Baseline (before nitroglycerin). Primary outcome: Magnitude of dilatation of coronary arteries.

What question did this study set out to answer?

The study aims to determine vasodilatory responses of large and small coronary arteries to nitroglycerin.

August 1, 1981Circulation

Magnitude of dilatation of large and small coronary arteries of nitroglycerin.

View Full Paper

Ask AI

Bookmark

Key result

Sublingual nitroglycerin induced coronary artery dilatation, with the greatest magnitude of vasodilatation observed in arteries with the smallest control diameter.

Why the study?

Does sublingual nitroglycerin improve vasodilatation differently based on the baseline size and location of coronary arteries?

Key Points

The study aims to determine vasodilatory responses of large and small coronary arteries to nitroglycerin.
34 patients were assessed using quantitative magnification coronary angiography.
Nitroglycerin (0.4 mg, sublingual) was administered prior to measurements.
Both large epicardial and small intramyocardial coronary arteries were evaluated for dilatation.
CAs with the smallest control diameter showed the greatest magnitude of vasodilation.
Coronary stenoses exhibited less dilation than nonstenosed segments of similar diameter.
No significant difference in response when excluding stenotic areas, regardless of coronary artery disease presence.

Structured PICO

Does sublingual nitroglycerin improve vasodilatation differently based on the baseline size and location of coronary arteries?

Population

34 patients evaluated for coronary artery vasodilatory responses before and after sublingual nitroglycerin.

Intervention

Nitroglycerin 0.4 mg sublingual.

Comparator

Baseline measurements (before nitroglycerin administration).

Outcome

Vasodilatory responses (magnitude of dilatation) of segments of large epicardial left coronary artery, small intramyocardial coronary arteries (0.3-1.0 mm), coronary stenoses, and coronary arteries filled by collaterals, measured by quantitative magnification coronary angiography.surrogate

The principal determinant of coronary artery vasodilatory response to sublingual nitroglycerin is the baseline size of the artery, with smaller vessels exhibiting greater dilatation.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Smaller arteries dilate more after nitroglycerin; leaves open whether baseline diameter should guide dosing in ischemia.

Cite This Study

Feldman et al. (1981) studied Patients undergoing coronary angiography (n=34). Nitroglycerin vs. Baseline (before nitroglycerin) was evaluated on Magnitude of dilatation of coronary arteries. Sublingual nitroglycerin induced coronary artery dilatation, with the greatest magnitude of vasodilatation observed in arteries with the smallest control diameter.

synapsesocial.com/papers/6a6d2c42660549caf2c2cd3a https://doi.org/10.1161/01.cir.64.2.324

Topics

Coronary CT angiography

View Full Paper

Ask AI

Bookmark

Magnitude of dilatation of large and small coronary arteries of nitroglycerin.

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Magnitude of dilatation of large and small coronary arteries of nitroglycerin.

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider